INDICATIONS AND USAGE NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.

Alzheimer-Type Dementia. Treatment of moderate-to-severe dementia. Tablet: 5 mg PO once daily initially; increased by increments of 5 mg/day each week; ...

28 авг. 2024 г. · Namenda is used to treat moderate to severe dementia of the Alzheimer's type. Namenda's mechanism of action is to help balance a brain chemical called ...

Memantine is an NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer's.

INDICATIONS AND USAGE NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.

27 июн. 2024 г. · Memantine is commonly used to treat moderate to severe dementia related to Alzheimer's disease. Memantine may also be used for other conditions as determined ...

INDICATIONS AND USAGE NAMENDA XR® is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.

5 июл. 2024 г. · Memantine (brand name Namenda) is an oral NMDA blocker that may be used to treat moderate to severe dementia in people with Alzheimer's disease. Side effects · Memantine Interactions · Memantine Dosage · Pregnancy & Lactation

INDICATIONS AND USAGE ... Namenda (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.